- Corporate Officers - G
- Greene Barry E
Insider Trading History of Greene Barry E
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Greene Barry E since 2006.
This trader's CIK number is 1291963.
At the time of last reporting, Greene Barry E was the Director of Karyopharm Therapeutics Inc.. (stock ticker symbol KPTI).
Also see all insider trading activities at Karyopharm Therapeutics Inc..
Note that in the past
Greene Barry E also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Sage Therapeutics, Inc. (SAGE) by Greene Barry E
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2021 | SAGE | 32,440 | $1,515,690 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Karyopharm Therapeutics Inc. (KPTI) by Greene Barry E
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2022 | KPTI | 0 | $0 | 0 | $0 | 7,576 | $11,250 |
2020 | KPTI | 0 | $0 | 0 | $0 | 3,030 | $99 |
2015 | KPTI | 3,000 | $87,939 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Alnylam Pharmaceuticals, Inc. (ALNY) by Greene Barry E
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2020 | ALNY | 0 | $0 | 89,060 | $12,400,134 | 93,991 | $1,172,269 |
2019 | ALNY | 0 | $0 | 58,913 | $5,301,580 | 58,913 | $967,940 |
2018 | ALNY | 0 | $0 | 38,460 | $5,503,049 | 0 | $0 |
2017 | ALNY | 0 | $0 | 162,131 | $18,346,000 | 173,975 | $4,385,268 |
2016 | ALNY | 0 | $0 | 0 | $0 | 16,540 | $134,304 |
2015 | ALNY | 0 | $0 | 67,379 | $8,422,375 | 94,351 | $1,397,289 |
2014 | ALNY | 0 | $0 | 55,500 | $5,250,104 | 64,800 | $445,684 |
2013 | ALNY | 0 | $0 | 70,880 | $1,872,382 | 82,080 | $143,271 |
2012 | ALNY | 2,427 | $24,986 | 0 | $0 | 0 | $0 |
2011 | ALNY | 2,145 | $14,984 | 0 | $0 | 0 | $0 |
2008 | ALNY | 0 | $0 | 35,440 | $1,202,372 | 30,889 | $29,344 |
2007 | ALNY | 0 | $0 | 37,500 | $1,162,692 | 0 | $0 |
2006 | ALNY | 0 | $0 | 12,500 | $258,875 | 0 | $0 |
Yearly summary of insider trading at Acorda Therapeutics Inc (ACOR) by Greene Barry E
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2018 | ACOR | 0 | $0 | 0 | $0 | 10,000 | $201,600 |
2017 | ACOR | 0 | $0 | 13,740 | $290,188 | 13,740 | $246,099 |
Insider trading activities at 4 companies by Greene Barry E:
1. Sage Therapeutics, Inc. (SAGE)
2. Karyopharm Therapeutics Inc. (KPTI)
3. Alnylam Pharmaceuticals, Inc. (ALNY)
4. Acorda Therapeutics Inc (ACOR)
Table 1. Insider trading of Sage Therapeutics, Inc. (SAGE) by Greene Barry E
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2021-08-05 | SAGE | Buy | 23,640 | 43.15 | 1,020,066 |
2021-06-16 | SAGE | Buy | 8,800 | 56.32 | 495,624 |
Table 2. Insider trading of Karyopharm Therapeutics Inc. (KPTI) by Greene Barry E
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2022-08-11 | KPTI | Option Ex | 7,576 | 1.49 | 11,250 |
2020-03-13 | KPTI | Option Ex | 3,030 | .03 | 99 |
2015-04-02 | KPTI | Buy | 3,000 | 29.31 | 87,939 |
Table 3. Insider trading of Alnylam Pharmaceuticals, Inc. (ALNY) by Greene Barry E
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2020-09-09 | ALNY | Option Ex | 44,530 | 9.14 | 407,004 |
2020-09-09 | ALNY | Sale | 44,530 | 123.48 | 5,498,430 |
2020-08-10 | ALNY | Option Ex | 4,931 | 72.66 | 358,261 |
2020-07-07 | ALNY | Option Ex | 22,265 | 9.14 | 203,502 |
2020-07-07 | ALNY | Sale | 22,265 | 159.99 | 3,562,177 |
2020-05-06 | ALNY | Option Ex | 22,265 | 9.14 | 203,502 |
2020-05-06 | ALNY | Sale | 22,265 | 149.99 | 3,339,527 |
2019-10-22 | ALNY | Option Ex | 58,913 | 16.43 | 967,940 |
2019-10-22 | ALNY | Sale | 58,913 | 89.99 | 5,301,580 |
2018-03-14 | ALNY | Sale | 38,460 | 143.09 | 5,503,049 |
2017-10-02 | ALNY | Option Ex | 85,316 | 21.35 | 1,821,496 |
2017-10-02 | ALNY | Sale | 85,316 | 125.00 | 10,664,500 |
2017-09-20 | ALNY | Option Ex | 76,815 | 31.39 | 2,411,222 |
2017-09-21 | ALNY | Option Ex | 11,844 | 12.88 | 152,550 |
2017-09-20 | ALNY | Sale | 76,815 | 100.00 | 7,681,500 |
2016-03-24 | ALNY | Option Ex | 16,540 | 8.12 | 134,304 |
2015-08-04 | ALNY | Option Ex | 26,972 | 19.03 | 513,277 |
2015-05-26 | ALNY | Option Ex | 67,379 | 13.12 | 884,012 |
2015-05-26 | ALNY | Sale | 67,379 | 125.00 | 8,422,375 |
2014-12-19 | ALNY | Sale | 11,200 | 100.00 | 1,120,000 |
2014-12-22 | ALNY | Option Ex | 1,000 | 13.12 | 13,120 |
2014-11-17 | ALNY | Sale | 33,200 | 90.97 | 3,020,104 |
2014-11-17 | ALNY | Option Ex | 33,200 | 6.78 | 225,096 |
2014-11-11 | ALNY | Sale | 11,100 | 100.00 | 1,110,000 |
2014-11-11 | ALNY | Option Ex | 11,100 | 6.78 | 75,258 |
2014-02-03 | ALNY | Option Ex | 19,500 | 6.78 | 132,210 |
2013-12-17 | ALNY | Option Ex | 11,200 | 6.78 | 75,936 |
2013-05-28 | ALNY | Option Ex | 22,822 | .95 | 21,680 |
2013-05-28 | ALNY | Sale | 22,822 | 30.00 | 684,660 |
2013-03-14 | ALNY | Sale | 24,058 | 25.00 | 601,450 |
2013-03-14 | ALNY | Option Ex | 24,058 | .95 | 22,855 |
2013-03-08 | ALNY | Option Ex | 24,000 | .95 | 22,800 |
2013-03-08 | ALNY | Sale | 24,000 | 24.43 | 586,272 |
2012-02-21 | ALNY | Buy | 1,860 | 10.75 | 19,995 |
2012-01-09 | ALNY | Buy | 567 | 8.80 | 4,991 |
2011-12-12 | ALNY | Buy | 699 | 7.15 | 4,995 |
2011-11-14 | ALNY | Buy | 704 | 7.09 | 4,994 |
2011-10-11 | ALNY | Buy | 742 | 6.73 | 4,995 |
2008-08-13 | ALNY | Option Ex | 30,889 | .95 | 29,344 |
2008-08-13 | ALNY | Sale | 35,440 | 33.93 | 1,202,372 |
2007-10-24 | ALNY | Sale | 21,700 | 30.79 | 668,186 |
2007-10-24 | ALNY | Sale | 10,580 | 31.13 | 329,387 |
2007-10-24 | ALNY | Sale | 5,220 | 31.63 | 165,119 |
2006-10-31 | ALNY | Sale | 12,500 | 20.71 | 258,875 |
Table 4. Insider trading of Acorda Therapeutics Inc (ACOR) by Greene Barry E
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2018-05-21 | ACOR | Option Ex | 10,000 | 20.16 | 201,600 |
2017-08-01 | ACOR | Sale | 10,000 | 21.57 | 215,700 |
2017-08-01 | ACOR | Option Ex | 10,000 | 18.21 | 182,100 |
2017-02-09 | ACOR | Sale | 723 | 22.65 | 16,375 |
2017-02-09 | ACOR | Option Ex | 723 | 22.13 | 15,999 |
2017-01-03 | ACOR | Option Ex | 3,017 | 15.91 | 48,000 |
2017-01-03 | ACOR | Sale | 3,017 | 19.26 | 58,113 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Greene Barry E
(Director of Karyopharm Therapeutics Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.